ClinicalTrials.govpublic full text
Prophylaxis Covid-19 in Healthcare Agents by Intensive Treatment With Ivermectin and Iota-carrageenan
covid19, sars (severe acute respiratory syndrome), ivermectin, iota-carrageenan, prophylaxis covid-19, healthcare agents, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 807616
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.